EICHOR
● Active Not Recruiting
Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis
Condition: Intracranial Arteriosclerosis · Stroke · Sponsor: University of Florida
About this study
The primary goal of the trial is to determine if the experimental arms (rivaroxaban or ticagrelor or both) are superior to the clopidogrel arm for lowering the 1-year rate of ischemic stroke, intracerebral hemorrhage, or vascular death.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (114)
| University of Alabama Hospital | Birmingham, Alabama, United States | — |
| University of South Alabama University Hospital | Mobile, Alabama, United States | — |
| St. Joseph's Hospital and Medical Center | Phoenix, Arizona, United States | — |
| Mercy San Juan Medical Center | Carmichael, California, United States | — |
| The Neuron Clinic - Chula Vista | Chula Vista, California, United States | — |
| Kaiser Permanente Fontana Medical Center | Fontana, California, United States | — |
| Long Beach Memorial Medical Center | Long Beach, California, United States | — |
| Los Alamitos Medical Center | Los Alamitos, California, United States | — |
| Kaiser Permanente Los Angeles Medical Center | Los Angeles, California, United States | — |
| Ronald Reagan UCLA Medical Center, Los Angeles, CA | Los Angeles, California, United States | — |
| UC Irvine Medical Center | Orange, California, United States | — |
| UC Davis Medical Center | Sacramento, California, United States | — |
+ 102 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05047172